Simplifying the process: regularizing products at ANVISA
Understand the essential steps for regularizing products with ANVISA and how QR Group can help your company ensure compliance quickly and safely. If you work in the industry of products that require regularization with the health surveillance agency, you know that regularizing products with ANVISA is a crucial step, not only for marketing, but also […]
Anvisa Launches Consultation Panel for Active Ingredients of Medications with Drug Registration Process
New Anvisa Tool Brings Transparency to the Brazilian Drug Registration Process Anvisa has just made available an online dashboard that allows users to consult the active ingredients of drugs with registration requests still under analysis. The tool is an innovation that promotes transparency in the regulatory process, offering a detailed view of the different categories […]
Spending on Medication Represents 33.7% of Brazilian Families Health Expenditure in 2021, According to IBGE
Understand how the Growth in Spending on Medication Impacts the Economy and QR Group’s Role in Access to Health Products In 2021, Brazilians spent R$168.3 billion on purchasing medications, representing 33.7% of household spending on healthcare, according to data from IBGE. This increase reflects both the impact of the pandemic and the aging of the […]
In Vitro Diagnostic Devices: Update on ANVISA’s Petitioning System under RDC 830/2023
QR Group provides guidance to international manufacturers on new regulatory requirements for in vitro diagnostic devices and how to adapt to RDC 830/2023 ANVISA will carry out an important update to its electronic petitioning system between May 29 and June 3 to comply with RDC 830/2023, which establishes new rules for the risk classification, registration, […]
